A profile of Craig Venter and his synthetic biology aspirations in The Atlantic Monthly may not do much for one scientist's modesty.
In this video, Sanger's Tim Hubbard presents the challenges of working with and keeping up with genomic data to the folks at Google.
Wired magazine ranks the top 10 cities where tech geeks rule the roost.
George Johnson reviews Freeman Dyson's latest book, a collection of essays from one of the translational pioneers in physics.
This week's issue of Newsweek includes a short profile of Thermal Gradient's high-speed DNA amplification technology.
A DNA-based vaccine for avian flu enters human trials, NIH says.
Today's issue of Science offers papers involving microRNAs and microfluidics, as well as a letter reflecting on a pattern in Nobel Prize awards.
This article from The Economist proves that for humans, like hot dogs, sometimes it's best not to know what's inside.
Nature's first issue of the new year doesn't disappoint.
Boise State researchers are seeking out DNA sequences that would be so threatening to life they actually don't exist in nature.
Retractions galore in the community, from the Taiwan team accused of image manipulation to the series of papers that featured incorrect data thanks to faulty software.
Mainstream media is picking up on the looming threat to the otherwise-promising personalized medicine: getting insurers to fork over the money.
NAR's Database Issue is out, and its editorial offers good practice advice for building a better repository.
The annual Darwin Awards release their winners for 2006. Their raison d'etre: "the improvement of the human genome by honoring those who accidentally remove themselves from it."
New imaging procedures published in CSH Protocols.
Discover magazine joins the publications taking a swing at the "best of 2006" lists with the top genetics stories as well as the top scientist of the year.
Bioinformaticists, rejoice: industry watchers are already spreading doubt about Microsoft's long-awaited Vista platform. How much do we love Linux? Let us count the ways.
A group within the US Centers for Disease Control tackles what others have deemed impossible, trying to elicit causes for unexplained deaths in cases that may be linked to pathogens or emerging infectious diseases.
Years after President Bush's stem cell decision, scientists are still struggling to comply with the rules while finding ways to advance their research.
An 'omics blogger gives a positive review to the Field Museum's Mendel exhibit.
Genetics and Health blogger prepares for the inevitable after the latest news out of Britain's National DNA Database.
In the superfamily tree, gibbons are among the more highly diverged species from humans. A PLoS Genetics paper says synteny breakpoints may well have been the fork in the road.
The US FDA finds no difference between meat from regular livestock and cloned livestock, and proposed greenlighting sales of cloned products without special labeling for consumers.
A blogger waxes poetic over the accomplishment of that less-celebrated nucleic acid.
A look back at the ups and downs of Human Genome Sciences' decade-and-a-half struggle to get a drug on the market.
A new analysis finds that better grant-writing skills may help early-career researchers stay funded and stay in academia.
At Nature, a graduate student describes how to explore careers outside academia and what PhD programs can do help that search.
A new analysis of research funding finds that after receiving their first award, female researchers are just about as likely to receive additional awards as male researchers.
The Nature Jobs blog reports that the University of Chicago is no longer requiring graduate school applicants to submit standardized test scores.